The International Journal of Neuropsychopharmacology
June 7, 2012
Wallace C. Duncan, Simone Sarasso, Fabio Ferrarelli et al.
253 citations
A single infusion of the NMDA receptor antagonist ketamine rapidly reduces depressive symptoms in patients with treatment-resistant major depressive disorder. In 30 patients, ketamine increased electroencephalogram slow wave activity during early non-REM sleep and raised plasma levels of brain-derived neurotrophic factor. The occurrence of high amplitude slow waves and their slope also increased, indicating enhanced synaptic strength. Changes in BDNF levels correlated with changes in EEG parameters, but only in patients who responded to ketamine. This suggests that enhanced synaptic plasticity, reflected by increased slow wave activity and BDNF, is part of the mechanism behind ketamine's rapid antidepressant effects.
PLoS ONE
August 28, 2013
Fabio Ferrarelli, Richard Smith, Daniela Dentico et al.
125 citations
Long-term Buddhist meditators with about 8,700 mean lifetime hours of practice show increased gamma power (25-40 Hz) in parietal-occipital regions during non-rapid eye movement sleep compared to meditation-naive individuals. This increase is specific to gamma frequencies, unrelated to spontaneous arousal levels during NREM sleep, and positively correlated with the length of lifetime daily meditation practice. The findings indicate that meditation practice produces measurable changes in spontaneous brain activity and suggest that EEG gamma activity during sleep may serve as a sensitive marker of long-lasting plastic effects of meditative training on brain function.
Scientific Reports
November 5, 2018
Matthieu Darracq, Chadd M. Funk, Daniel Polyakov et al.
49 citations
Sleep and anesthesia alter conscious experience, which can be absent (unconsciousness) or take the form of dreaming where sensory stimuli are not incorporated (disconnected consciousness). Using transcranial magnetic stimulation-electroencephalography over parietal regions, evoked alpha power (8-12 Hz) decreased during disconnected consciousness in rapid eye movement sleep and ketamine anesthesia compared to wakefulness. In unconscious states of propofol anesthesia and non-rapid eye movement sleep, evoked low-gamma power (30-40 Hz) decreased compared to wakefulness or disconnected consciousness. These findings, confirmed with dream reports from serial awakenings, suggest suppression of evoked alpha activity may mark sensory disconnection.
PLoS ONE
February 22, 2016
Daniela Dentico, Fabio Ferrarelli, Brady A. Riedner et al.
43 citations
After two intensive days of mindfulness or compassion meditation, long-term meditators showed increased low-frequency brain activity (1-12 Hz, peaking around 7-8 Hz) over prefrontal and left parietal areas during non-rapid eye movement sleep. This increase was strongest early in the night and extended to higher frequencies (25-40 Hz) during the third sleep cycle. The changes depended on meditation experience and did not differ between the two meditation styles. No such changes occurred in meditation-naive individuals. The findings suggest that intensive meditation practice acutely alters brain activity in regions linked to top-down regulation, complementing chronic changes seen in posterior areas.
European Journal of Neuroscience
August 24, 2018
Daniela Dentico, David R. W. Bachhuber, Brady A. Riedner et al.
18 citations
Long-term meditators showed increased low- and fast-frequency brain oscillations during wakefulness after two 8-hour sessions of mindfulness or compassion-and-loving-kindness meditation, peaking at 8 and 15 Hz over prefrontal and left centro-parietal electrodes. These waking changes correlated with previously observed meditation-related increases in low-frequency NREM sleep EEG activity (4-12 Hz), particularly in the theta-alpha range. The findings suggest that sleep homeostatic response alone cannot explain the post-meditation sleep changes; instead, a reverberation of meditation-related processes during subsequent sleep may be involved. No differences emerged between meditation styles or in meditation-naïve participants.
bioRxiv (Cold Spring Harbor Laboratory)
June 13, 2024
Christopher R. Nicholas, Matthew I. Banks, Richard Lennertz et al.
3 citations
preprint
Co-administering the amnestic benzodiazepine midazolam with psilocybin in 8 healthy participants partially impaired memory for the psychedelic experience while still allowing a conscious experience to occur. The degree of memory impairment was inversely associated with salience, insight, and well-being induced by psilocybin. These results suggest that memory of the acute psychedelic experience contributes to therapeutically relevant behavioral effects. Because midazolam blocks memory by blocking cortical neural plasticity, it may also help evaluate how the pro-neuroplastic properties of psychedelics contribute to their therapeutic activity.
bioRxiv (Cold Spring Harbor Laboratory)
July 29, 2025
May Kung Sutherland, Christopher R. Nicholas, Richard Lennertz et al.
preprint
Psilocybin, a serotonergic psychedelic, induces neural plasticity and alters consciousness, while midazolam, a benzodiazepine, blunts plasticity and causes sedation and amnesia. In an open-label pilot study, 25 mg of oral psilocybin was given alongside intravenous midazolam at doses that allowed a full psychedelic experience but reduced memory of it. EEG recordings showed that 15-30 minutes after dosing, when midazolam was at its target concentration, beta power increased and the spectral exponent decreased. As psilocybin's effects emerged over the next six hours, Lempel-Ziv complexity and spectral exponent increased while broadband power decreased. These findings suggest psilocybin's effects persist even with midazolam, supporting its use in mechanistic studies.